§ Federal grant opportunity · PAR-26-119
NEI Collaborative Clinical Vision Research (UG1 - Clinical Trial Optional)
National Institutes of Health is accepting applications for NEI Collaborative Clinical Vision Research (UG1 - Clinical Trial Optional). The deadline is Rolling / not published and the published award range is Award amount not published.
Key facts
- Funder
- National Institutes of Health
- Application deadline
- Rolling / not published
- Award range
- Award amount not published
- Eligibility
- state governments, city or township governments, other, nonprofits non higher education without 501c3, public and indian housing authorities, other native american tribal organizations, special district governments, small businesses, public and state institutions of higher education, private institutions of higher education, for profit organizations other than small businesses, county governments, nonprofits non higher education with 501c3, federally recognized native american tribal governments, independent school districts
- Geography
- United States
- Focus areas
- Health
- Opportunity number
- PAR-26-119
Program overview
The NEI uses UG1 cooperative agreement awards to support investigator-initiated clinical vision research projects, including multi-center clinical trials, human gene-transfer, stem cell therapy trials, epidemiological studies, and other studies that are complex, high resource, or that require increased oversight due to elevated safety considerations. These collaborative clinical vision research projects would address chronic diseases across the lifespan through research on the burden of eye and vision conditions, their causes, diagnoses, prevention, treatment, and rehabilitation. These projects are multifaceted and of high public health significance, requiring careful oversight and monitoring by National Institutes of Health (NIH) staff. The intent of this funding opportunity announcement is to provide a collaborative framework for the following components: Chair's Grant, Coordinating Center, and Resource Center(s).
How to apply
- Confirm your organization meets the eligibility criteria above.
- Read the full funding opportunity announcement from National Institutes of Health.
- Draft your narrative against the funder's stated priorities and review criteria.
- Submit before Rolling / not published, allowing time for registration and validation.
Related grant opportunities
- Expanding the Therapeutic Pipeline for Treating and Preventing Alzheimer's Disease and Related Dementias: Preclinical Validation and Drug Discovery for Novel Candidate Targets (U01 Clinical Trial Not Allowed)
- Notice of Funding Opportunity for the Fiscal Year 2025 and 2026 Consolidated Rail Infrastructure and Safety Improvements Program
- Precision Approaches in Radiation Synthetic Combinations (PAIRS, RP1 Clinical Trial Optional)
- Network of the National Library of Medicine Coordinating Center (U24 Clinical Trial Optional)
- Biomechanics and Mechanobiology (BMMB)
Find every grant your organization qualifies for
Mavenly scores this opportunity against your mission, geography, and funding history — then drafts the proposal with you and tracks the deadline through submission and reporting.